• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Long-term local tolerability to intranasally administered salmon calcitonin in post-menopausal osteoporosis].

作者信息

Gariboldi L M, Bolla I, Baroni M C, Delsignore R, Passeri M, Barberis F

机构信息

Istituto Policattedra di Clinica Otorinolaringoiatrica, Università degli Studi di Parma.

出版信息

Minerva Med. 1992 Dec;83(12):827-31.

PMID:1491763
Abstract

The aim of this study was to acquire further knowledge relative to the local tolerability of synthetic salmon Calcitonin, administered by the intranasal route. The Authors have evaluated several olfactometry parameters in a group of patients treated for twelve months with the drug. The Wright matrix test and the olfacto-respiratory reflex test were performed. An evaluation regarding mucociliary transport time was additionally effected. No interference on the part of the drug was reported regarding the functional parameters of the nasal mucosa. The excellent local tolerability of intranasal salmon Calcitonin, as already indicated by other Authors, was confirmed, even in terms of specific parameters relative to the olfactory functions.

摘要

相似文献

1
[Long-term local tolerability to intranasally administered salmon calcitonin in post-menopausal osteoporosis].
Minerva Med. 1992 Dec;83(12):827-31.
2
[Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].鲑鱼降钙素鼻内给药1年治疗绝经后骨质疏松症稳定期的临床疗效
Minerva Endocrinol. 1989 Jul-Sep;14(3):169-76.
3
[Comparison of calcitonin tolerance after intramuscular or intranasal administration in treatment for postmenopausal osteoporosis].
Przegl Lek. 1996;53(1):9-11.
4
Calcitonin.降钙素
Am J Med Sci. 1997 Jan;313(1):13-6. doi: 10.1097/00000441-199701000-00003.
5
Calcitonin intranasal--unigene: Salcatonin intranasal--unigene.鼻内降钙素——单基因:鼻内鲑降钙素——单基因。
Drugs R D. 2004;5(2):90-3. doi: 10.2165/00126839-200405020-00004.
6
[Multicenter comparative study of synthetic salmon calcitonin administered nasally in the treatment of established postmenopausal osteoporosis].[合成鲑鱼降钙素经鼻给药治疗已确诊的绝经后骨质疏松症的多中心对照研究]
An Med Interna. 1995 Jan;12(1):12-6.
7
Calcitonin and the treatment of osteoporosis.
Md Med J. 1991 Jun;40(6):469-73.
8
Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis.鲑鱼降钙素鼻喷雾剂对高转换型骨质疏松症患者骨量的影响。
Osteoporos Int. 1993;3 Suppl 1:208-10. doi: 10.1007/BF01621909.
9
Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women.阿仑膦酸钠与鼻内降钙素治疗绝经后妇女骨质疏松症的比较。
J Clin Endocrinol Metab. 2000 May;85(5):1783-8. doi: 10.1210/jcem.85.5.6606.
10
Oral salmon calcitonin--pharmacology in osteoporosis.口服鲑鱼降钙素——骨质疏松症的药理学。
Expert Opin Biol Ther. 2010 Nov;10(11):1617-29. doi: 10.1517/14712598.2010.526104. Epub 2010 Oct 11.

引用本文的文献

1
Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis.鼻内用鲑降钙素(鲑鱼降钙素)。其药理学特性及在绝经后骨质疏松症管理中的作用综述。
Drugs Aging. 1996 May;8(5):378-400. doi: 10.2165/00002512-199608050-00006.